Glubio Pharmaceutical Raises $50M Series A

02/28/22, 11:29 AM

Money raised

$50 million

Round Type

series a

GluBio Pharmaceutical has secured nearly $50 million in a Series A round of financing, bringing the total capital raised by the drugmaker to $70 million, it said in a statement on Monday.

Company Info

Company

Glu Bio Pharmaceutical

Additional Info

Proceeds from the financing will be used for tapping pipeline candidates, platform upgradation, and talent acquisition, the company said.